The genetic variants underlying breast cancer treatment-induced chronic and late toxicities: a systematic review

Cancer Treat Rev. 2014 Dec;40(10):1199-214. doi: 10.1016/j.ctrv.2014.10.001. Epub 2014 Oct 14.

Abstract

A systematic review was performed to describe the findings from 19 genetic association studies that have examined the genetic variants underlying four common treatment-induced chronic and late toxicities in breast cancer patients, and to evaluate the quality of reporting. Three out of 5 studies found an association between HER2 lle655Val polymorphisms and trastuzumab-induced cardiotoxicity. Two studies found a positive association between cognitive impairment and the Val allele of the COMT gene and the ε4 allele of the apolipoprotein E gene. Genetic associations were established between fatigue and the G/G genotype of IL6-174 and TNF-308, and the Met allele of the COMT gene in 4 studies. Among studies (N=8) that evaluated the genetic associations underlying peripheral neuropathy, CYP2C8∗3 variant is commonly reported as the associated gene. Most studies failed to conform to the major criteria listed in the STREGA guidelines, with a lack of transparent reporting of methods and results.

Keywords: Breast cancer; Cardiotoxicity; Cognitive dysfunction; Fatigue; Genetic association; Peripheral neuropathy.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Apolipoproteins E / genetics
  • Aryl Hydrocarbon Hydroxylases / genetics
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / genetics*
  • Cardiovascular Diseases / chemically induced*
  • Cardiovascular Diseases / genetics
  • Catechol O-Methyltransferase / genetics
  • Cognition Disorders / chemically induced*
  • Cognition Disorders / genetics
  • Cytochrome P-450 CYP2C8 / genetics
  • Fatigue / chemically induced*
  • Fatigue / genetics
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Interleukin-6 / genetics
  • Peripheral Nervous System Diseases / chemically induced*
  • Peripheral Nervous System Diseases / genetics
  • Polymorphism, Genetic*
  • Polymorphism, Single Nucleotide
  • Receptor, ErbB-2 / genetics

Substances

  • Antineoplastic Agents
  • Apolipoproteins E
  • IL6 protein, human
  • Interleukin-6
  • Aryl Hydrocarbon Hydroxylases
  • CYP2C8 protein, human
  • Cytochrome P-450 CYP2C8
  • COMT protein, human
  • Catechol O-Methyltransferase
  • ERBB2 protein, human
  • Receptor, ErbB-2